title: The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.
abstract: Over the years since 1961 and the identification of thalidomide as the common link in thousands of birth defects, daily pharmacovigilance activities and signal generation have evolved from the analysis of individual case reports and imputology, to case series and underreporting, to spontaneous report databases and disproportionality analyses, to data mining in population databases. Regulatory requirements have also changed from purely passive monitoring and reacting to alerts to a proactive approach that includes risk management plans and risk minimization, and from reporting only by healthcare professionals to patient reporting and exploration of social media. The emphasis only on risk assessment is changing towards assessment of the risk/benefit ratio and the exploration of real-life efficacy studies to complement the measure of real-life risk. The interactions between industry and regulators have been amplified and strengthened. However, most adverse reactions, including severe ones, are related to well-known and often pharmacological effects of the older drugs, possibly with genetic predispositions. Prevention is the next frontier for pharmacovigilance, beyond simply generating alerts, and it involves not only the removal of drugs from the market, but also promotion of proper drug prescribing by better trained physicians and the proper use of drugs by better informed patients.
authors: Department of Pharmacology, INSERM U657, CIC-P0005, University of Bordeaux, Bordeaux, France. nicholas.moore@pharmaco.u-bordeaux2.fr
authors: Nicholas
authors: N
authors: Moore
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions; D005544:Forecasting; D006801:Humans; D060735:Pharmacovigilance
references: Drug Saf. 2005;28(1):35-51
references: 15649104
references: Br J Clin Pharmacol. 1997 Feb;43(2):177-81
references: 9131950
references: Br J Clin Pharmacol. 2008 Jul;66(1):142-5
references: 18507660
references: Eur J Clin Pharmacol. 2013 Mar;69(3):605-16
references: 22878690
references: Eur J Clin Pharmacol. 2004 Sep;60(7):523-9
references: 15338086
references: Br J Clin Pharmacol. 1998 Mar;45(3):301-8
references: 9517375
references: Chem Immunol Allergy. 2012;97:18-31
references: 22613851
references: Basic Clin Pharmacol Toxicol. 2010 Jul;107(1):531-59
references: 20590536
references: Am J Ther. 2003 Nov-Dec;10(6):462-4
references: 14624287
references: Aust N Z J Med. 1990 Jun;20(3):275-82
references: 2196873
references: BMJ. 2000 Apr 15;320(7241):1036
references: 10764362
references: Clin Pharmacol Ther. 1986 Oct;40(4):451-61
references: 3757408
references: Therapie. 1987 Mar-Apr;42(2):231-7
references: 3617000
references: J Clin Epidemiol. 1996 Jan;49(1):121-3
references: 8598505
references: J Trauma. 2011 Apr;70(4):906-9
references: 21610395
references: Drug Saf. 2010 Nov 1;33(11):1045-54
references: 20925441
references: Pain. 2001 Apr;91(3):401-402
references: 11383513
references: N Engl J Med. 1986 Jun 12;314(24):1589-92
references: 3713757
references: Drug Saf. 2006;29(10):875-87
references: 16970511
references: J Clin Epidemiol. 1992 Oct;45(10):1177-84
references: 1474414
references: Clin Pharmacol Ther. 1981 Aug;30(2):239-45
references: 7249508
references: Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:41-9
references: 22262592
references: Pain. 2000 Mar;85(1-2):169-82
references: 10692616
references: Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:1-8
references: 22262586
references: Eur J Clin Pharmacol. 1998 Aug;54(6):483-8
references: 9776440
references: Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1166-71
references: 20848561
references: Drug Saf. 2007;30(10):891-8
references: 17867726
references: Drug Saf. 2009;32(5):441-7
references: 19419238
references: Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:32-40
references: 22262591
references: J Clin Pharm Ther. 2003 Apr;28(2):137-43
references: 12713611
references: J Clin Epidemiol. 2012 Oct;65(10):1069-77
references: 22910538
references: Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):519-23
references: 15317031
references: Epidemiology. 2012 Mar;23(2):238-46
references: 22266893
references: Eur Heart J. 2012 Aug;33(15):1893-901
references: 22711757
references: Drug Saf. 2002;25(6):393-7
references: 12071775
references: Therapie. 2006 Sep-Oct;61(5):439-46
references: 17243273
references: Br J Clin Pharmacol. 1991 Oct;32(4):407-8
references: 1958431
references: Clin Pharmacol Ther. 2012 May;91(5):838-45
references: 22472991
references: J Clin Epidemiol. 2006 Mar;59(3):308-14
references: 16488362
references: Pharmacoepidemiol Drug Saf. 2003 Jun;12(4):271-81
references: 12812006
references: BMJ. 2005 Mar 5;330(7490):539-40
references: 15746143
references: Clin Pharmacol Ther. 2007 Aug;82(2):157-66
references: 17538548
references: Stat Med. 1991 Jun;10(6):991-9
references: 1876790
references: Am J Hosp Pharm. 1978 Aug;35(8):929-32
references: 677138
references: Implement Sci. 2012 Sep 11;7:86
references: 22967756
references: Basic Clin Pharmacol Toxicol. 2007 Dec;101(6):395-400
references: 17927690
references: Br J Clin Pharmacol. 1999 Mar;47(3):329-31
references: 10215758
references: Drug Saf. 2011 Oct 1;34(10):881-2
references: 21879782
references: Br J Clin Pharmacol. 2010 Mar;69(3):295-302
references: 20233201
references: BMJ. 2006 Oct 7;333(7571):756
references: 17023482
references: Eur J Clin Pharmacol. 2011 Jul;67(7):681-6
references: 21597972
references: Pharmacoepidemiol Drug Saf. 2001 Oct-Nov;10(6):483-6
references: 11828828
references: Drug Saf. 1997 Oct;17(4):265-75
references: 9352962
references: Therapie. 1985 Mar-Apr;40(2):111-8
references: 4002188
references: Drugs. 2002;62(11):1649-71
references: 12109926
references: Therapie. 1974 Nov-Dec;29(6):799-804
references: 4462229
references: Psychopharmacol Bull. 1987;23(3):395-9
references: 3432510
references: Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):697-709
references: 22162077
references: Arch Intern Med. 2012 Jul 9;172(13):1039-41
references: 22641170
references: Eur J Clin Pharmacol. 2013 Mar;69(3):549-57
references: 22763756
references: Pharmacoepidemiol Drug Saf. 2012 Jan;21 Suppl 1:12-7
references: 22262588
references: Drugs Aging. 2008;25(1):61-70
references: 18184030
references: Drug Saf. 2010 Dec 1;33(12):1081-8
references: 21077699
references: Drug Saf. 2011 Oct 1;34(10):861-8
references: 21879780
references: Eur J Clin Pharmacol. 1998 Jun;54(4):315-21
references: 9696956
references: Drug Saf. 2012 Nov 1;35(11):1061-72
references: 23061782
references: BMJ Qual Saf. 2013 Feb;22(2):97-102
references: 23112288
references: BMJ. 2004 Jul 3;329(7456):15-9
references: 15231615
references: Ann Pharmacother. 1993 Jul-Aug;27(7-8):832-40
references: 8364259
references: Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):160-7
references: 23166053
references: Clin Pharmacol Ther. 2001 Jun;69(6):458-62
references: 11406744
references: J Clin Epidemiol. 1992 Mar;45(3):283-6
references: 1569425
references: Drug Saf. 2013 Feb;36(2):135-44
references: 23325533
references: J Allergy Clin Immunol. 2011 Mar;127(3 Suppl):S60-6
references: 21354501
references: Br J Clin Pharmacol. 2008 Jul;66(1):128-34
references: 18492128
references: Br Med J. 1977 Oct 15;2(6093):1001-3
references: 922357
references: Am J Ther. 2000 Mar;7(2):115-21
references: 11319579
references: Eur J Clin Pharmacol. 1998 Jan;53(5):299-302
references: 9516026
references: Diabetologia. 2012 Mar;55(3):644-53
references: 22222504
references: Stroke. 2011 Sep;42(9):2431-5
references: 21799168
references: Drug Saf. 2007;30(7):623-5
references: 17604417
references: Eur J Clin Pharmacol. 2000 Dec;56(9-10):763-7
references: 11214789
references: Pharmacoepidemiol Drug Saf. 2010 Dec;19(12):1256-62
references: 20945504
references: Stud Health Technol Inform. 2009;148:43-9
references: 19745234
references: Drug Saf. 2012 May 1;35(5):373-85
references: 22480319
references: Pharmacoepidemiol Drug Saf. 2005 Apr;14(4):285-6
references: 15782397
references: Pharmacoepidemiol Drug Saf. 2007 Aug;16(8):891-900
references: 17351983
references: Therapie. 1974 Nov-Dec;29(6):805-10
references: 4282425
references: Clin Pharmacol Ther. 2010 Jun;87(6):727-34
references: 20410877
references: Stud Health Technol Inform. 2011;166:25-30
references: 21685607
references: Drug Saf. 1994 Feb;10(2):93-102
references: 8011183
references: Pharmacoepidemiol Drug Saf. 2002 Jan-Feb;11(1):3-10
references: 11998548
references: Drug Saf. 2010 Sep 1;33(9):775-88
references: 20701410
references: N Engl J Med. 2011 Feb 10;364(6):498-9
references: 21226658
references: Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):525-6; discussion 527-8
references: 15317032
references: Drug Saf. 2012 Oct 1;35(10):855-64
references: 22967190
references: Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):286-91
references: 21351310
references: Novartis Found Symp. 2005;266:251-80; discussion 280-5
references: 16050273
references: JAMA. 2002 Oct 2;288(13):1588
references: 12350188
references: N Engl J Med. 2009 Aug 13;361(7):645-7
references: 19635947
references: Drug Saf. 2010 Jun 1;33(6):463-74
references: 20486729
references: Pharmacoepidemiol Drug Saf. 2003 Sep;12(6):517-21
references: 14513665
references: Pacing Clin Electrophysiol. 1986 Nov;9(6):836-41
references: 2432486
references: Drug Saf. 2007;30(4):357-66
references: 17408312
references: Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11
references: 21182150
references: Br J Clin Pharmacol. 1997 Nov;44(5):513-8
references: 9384470
references: Drug Saf. 2012 Jun 1;35(6):471-80
references: 22540371
references: Lancet. 1993 Jan 2;341(8836):61
references: 8093315
references: Lancet. 1985 Nov 9;2(8463):1056-8
references: 2865527
references: Br J Clin Pharmacol. 1994 Nov;38(5):401-4
references: 7893579
references: Br J Clin Pharmacol. 2011 Jan;71(1):29-33
references: 21143498
references: Can J Hosp Pharm. 1976 Sep-Oct;29(5):146, 164
references: 1030374
references: Eur J Clin Pharmacol. 2013 Jun;69(6):1275-83
references: 23307232
references: Circulation. 2012 Mar 20;125(11):1414-23
references: 22319105